These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9429233)

  • 1. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.
    Thompson J; Thomas N; Singleton A; Piggott M; Lloyd S; Perry EK; Morris CM; Perry RH; Ferrier IN; Court JA
    Pharmacogenetics; 1997 Dec; 7(6):479-84. PubMed ID: 9429233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.
    Suzuki A; Mihara K; Kondo T; Tanaka O; Nagashima U; Otani K; Kaneko S
    Pharmacogenetics; 2000 Jun; 10(4):335-41. PubMed ID: 10862524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients.
    Suzuki A; Kondo T; Mihara K; Furukori H; Nagashima U; Ono S; Otani K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Oct; 24(7):1105-13. PubMed ID: 11131175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects.
    Bartrés-Faz D; Junqué C; Serra-Grabulosa JM; López-Alomar A; Moya A; Bargalló N; Mercader JM; Moral P; Clemente IC
    Neuroreport; 2002 Jul; 13(9):1121-5. PubMed ID: 12151753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.
    Laruelle M; Gelernter J; Innis RB
    Mol Psychiatry; 1998 May; 3(3):261-5. PubMed ID: 9672902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.
    Mihara K; Suzuki A; Kondo T; Yasui-Furukori N; Ono S; Otani K; Kaneko S; Inoue Y
    Am J Med Genet; 2001 Apr; 105(3):271-4. PubMed ID: 11353448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.
    Jönsson EG; Nöthen MM; Grünhage F; Farde L; Nakashima Y; Propping P; Sedvall GC
    Mol Psychiatry; 1999 May; 4(3):290-6. PubMed ID: 10395223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
    J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.
    Smith CT; Dang LC; Buckholtz JW; Tetreault AM; Cowan RL; Kessler RM; Zald DH
    Transl Psychiatry; 2017 Apr; 7(4):e1091. PubMed ID: 28398340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI.
    Wagner AK; Scanlon JM; Becker CR; Ritter AC; Niyonkuru C; Dixon CE; Conley YP; Price JC
    J Cereb Blood Flow Metab; 2014 Aug; 34(8):1328-39. PubMed ID: 24849661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
    Mihara K; Kondo T; Suzuki A; Yasui N; Nagashima U; Ono S; Otani K; Kaneko S
    Psychopharmacology (Berl); 2000 Apr; 149(3):246-50. PubMed ID: 10823405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism.
    Ishiguro H; Arinami T; Saito T; Akazawa S; Enomoto M; Mitushio H; Fujishiro H; Tada K; Akimoto Y; Mifune H; Shioduka S; Hamaguchi H; Toru M; Shibuya H
    Alcohol Clin Exp Res; 1998 Jun; 22(4):845-8. PubMed ID: 9660310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome.
    Suzuki A; Kondo T; Otani K; Mihara K; Yasui-Furukori N; Sano A; Koshiro K; Kaneko S
    Am J Psychiatry; 2001 Oct; 158(10):1714-6. PubMed ID: 11579007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects.
    Laakso A; Pohjalainen T; Bergman J; Kajander J; Haaparanta M; Solin O; Syvälahti E; Hietala J
    Pharmacogenet Genomics; 2005 Jun; 15(6):387-91. PubMed ID: 15900211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
    Hirvonen MM; Laakso A; Någren K; Rinne JO; Pohjalainen T; Hietala J
    Synapse; 2009 Oct; 63(10):907-12. PubMed ID: 19582781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small.
    Berggren U; Fahlke C; Aronsson E; Karanti A; Eriksson M; Blennow K; Thelle D; Zetterberg H; Balldin J
    Alcohol Alcohol; 2006; 41(5):479-85. PubMed ID: 16751215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism.
    Kunii Y; Miura I; Matsumoto J; Hino M; Wada A; Niwa S; Nawa H; Sakai M; Someya T; Takahashi H; Kakita A; Yabe H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():123-8. PubMed ID: 24704945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.